384 related articles for article (PubMed ID: 21507989)
1. Thalidomide: the tragedy of birth defects and the effective treatment of disease.
Kim JH; Scialli AR
Toxicol Sci; 2011 Jul; 122(1):1-6. PubMed ID: 21507989
[TBL] [Abstract][Full Text] [Related]
2. [Thalidomide--new prospective therapy in oncology].
Pałgan K; Pałgan I
Wiad Lek; 2003; 56(9-10):455-9. PubMed ID: 15049211
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide use: past history and current implications for practice.
Goldman DA
Oncol Nurs Forum; 2001 Apr; 28(3):471-7; quiz 478-9. PubMed ID: 11338756
[TBL] [Abstract][Full Text] [Related]
4. [Thalidomide: new uses for an old drug].
Wu KL; Sonneveld P
Ned Tijdschr Geneeskd; 2002 Aug; 146(31):1438-41. PubMed ID: 12190008
[TBL] [Abstract][Full Text] [Related]
5. [The thalidomide experience: review of its effects 50 years later].
Martínez-Frías ML
Med Clin (Barc); 2012 Jun; 139(1):25-32. PubMed ID: 22177324
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide, a current teratogen in South America.
Castilla EE; Ashton-Prolla P; Barreda-Mejia E; Brunoni D; Cavalcanti DP; Correa-Neto J; Delgadillo JL; Dutra MG; Felix T; Giraldo A; Juarez N; Lopez-Camelo JS; Nazer J; Orioli IM; Paz JE; Pessoto MA; Pina-Neto JM; Quadrelli R; Rittler M; Rueda S; Saltos M; Sánchez O; Schüler L
Teratology; 1996 Dec; 54(6):273-7. PubMed ID: 9098920
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of action and potential therapeutic uses of thalidomide.
Mujagić H; Chabner BA; Mujagić Z
Croat Med J; 2002 Jun; 43(3):274-85. PubMed ID: 12035132
[TBL] [Abstract][Full Text] [Related]
8. Thalidomide: present and future in multiple myeloma.
Hussein MA
Expert Rev Anticancer Ther; 2005 Feb; 5(1):25-31. PubMed ID: 15757435
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide for the treatment of multiple myeloma.
Hattori Y; Iguchi T
Congenit Anom (Kyoto); 2004 Sep; 44(3):125-36. PubMed ID: 15327481
[TBL] [Abstract][Full Text] [Related]
10. Thalidomid: current role in the treatment of non-plasma cell malignancies.
Kumar S; Witzig TE; Rajkumar SV
J Clin Oncol; 2004 Jun; 22(12):2477-88. PubMed ID: 15197211
[TBL] [Abstract][Full Text] [Related]
11. Deciphering the mystery of thalidomide teratogenicity.
Ito T; Handa H
Congenit Anom (Kyoto); 2012 Mar; 52(1):1-7. PubMed ID: 22348778
[TBL] [Abstract][Full Text] [Related]
12. [Thalidomide epidemics: 50 years after].
Sípek A; Sípek A; Maňáková E
Cas Lek Cesk; 2012; 151(12):579-81. PubMed ID: 23387816
[TBL] [Abstract][Full Text] [Related]
13. Leukocytoclastic vasculitis due to thalidomide in multiple myeloma.
Yildirim ND; Ayer M; Küçükkaya RD; Alpay N; Mete O; Yenerel MN; Yavuz AS; Nalçaci M
Jpn J Clin Oncol; 2007 Sep; 37(9):704-7. PubMed ID: 17709605
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide in the treatment of multiple myeloma.
Rajkumar SV
Expert Rev Anticancer Ther; 2001 Jun; 1(1):20-8. PubMed ID: 12113124
[TBL] [Abstract][Full Text] [Related]
15. A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma.
Rajkumar SV; Witzig TE
Cancer Treat Rev; 2000 Oct; 26(5):351-62. PubMed ID: 11006136
[TBL] [Abstract][Full Text] [Related]
16. [Thalidomide in oncological and hematological diseases].
Kivivuori SM; Anttila P
Duodecim; 2010; 126(12):1413-9. PubMed ID: 20617746
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide makes a comeback.
Dodd-Butera T; Broderick M
RN; 2003 May; 66(5):32-5; quiz 36. PubMed ID: 12778690
[No Abstract] [Full Text] [Related]
18. Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide.
Witzens M; Moehler T; Neben K; Fruehauf S; Hartschuh W; Ho AD; Goldschmidt H
Ann Hematol; 2004 Jul; 83(7):467-70. PubMed ID: 14625789
[TBL] [Abstract][Full Text] [Related]
19. Thalidomide approved.
Posit Aware; 1998; 9(5):16. PubMed ID: 11365882
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide-induced teratogenesis: history and mechanisms.
Vargesson N
Birth Defects Res C Embryo Today; 2015 Jun; 105(2):140-56. PubMed ID: 26043938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
